Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

NCT03259035 is registered in ClinicalTrials.gov with Canadian Cancer Trials Group as lead sponsor.

NCT NCT03259035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03259035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Lead sponsor
Canadian Cancer Trials Group
Phase
Phase 2
Overall status
Completed
Start date
June 29, 2018
Completion date
April 25, 2024
Enrollment
58 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer